Akshar Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 26254.34%
- Profit Growth 235.35%
- Ebitda 347.89%
- Net Worth 131.11%
- Total Assets 98.60%
About Akshar Biotech
Akshar Biotech Private Limited (ABPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 05 May 2017 (Seven years and nine months 20 days old ). Its registered office is in Surat, Gujarat, India.
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ramdas Lashkari, Bharatbhai Savaliya, Sonal Savaliya, and One other member serve as directors at the Company.
Company Details
- Location
Surat, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U29309GJ2017PTC097247
- Company No.
097247
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 May 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Akshar Biotech Private Limited offer?
Akshar Biotech Private Limited offers a wide range of products and services, including Oxygen & Nitrogen Gas Plants, Biogas Plant.
Who are the key members and board of directors at Akshar Biotech?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramdas Lashkari  | Director | 01-Jul-2021 | Current |
| Bharatbhai Savaliya | Director | 05-May-2017 | Current |
| Sonal Savaliya | Director | 01-Jul-2020 | Current |
| Sadhanaben Savaliya | Director | 01-Jul-2021 | Current |
Financial Performance of Akshar Biotech.
Akshar Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26254.34% increase. The company also saw a substantial improvement in profitability, with a 235.35% increase in profit. The company's net worth Soared by an impressive increase of 131.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Akshar Biotech?
In 2023, Akshar Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aksharam Bioscience Technology LlpBharatbhai Savaliya is a mutual person
- Shukhdham Renewable Energy Private Limited
Bharatbhai Savaliya and Sonal Savaliya are mutual person
- Skylar Corporate Private Limited
Sadhanaben Savaliya is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Akshar Biotech?
Akshar Biotech has a workforce of 5 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akshar Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akshar Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
